Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunit Das

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Frontiers in Oncology|December 15, 2022
High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first reportChia-Lin Tseng, Hanbo Chen, James Stewart, et al.
Technology in Cancer Research & Treatment|June 28, 2022
Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort AnalysisJames Stewart, Arjun Sahgal, Aimee K M Chan, et al.
The Lancet. Oncology|May 14, 2026
MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trialJay S Detsky, Adrian Wai Chan, Daniel Moore-Palhares, et al.
Data in Brief|April 14, 2021
ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastomaPejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2021
Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastomaPejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Fractionated radiotherapy for surgically resected intracranial meningiomas: A multicentre retrospective cohort studyJustin Z Wang, Farshad Nassiri, Alexander P Landry, et al.
Nature Genetics|June 22, 2026
Longitudinal changes in DNA methylation in IDH-mutant glioma fuel disease progression through altered cell state differentiationMasashi Nomura, Ramya Raviram, Joshua S Schiffman, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 5, 2024
ChatGPT and neurosurgical education: A crossroads of innovation and opportunitySaman Arfaie, Mohammad Sadegh Mashayekhi, Mohammad Mofatteh, et al.
Frontiers in Oncology|October 8, 2024
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyondAnaliz Rodriguez, Manmeet S Ahluwalia, Chetan Bettegowda, et al.
Cell Stem Cell|July 18, 2017
ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem CellsNicole I Park, Paul Guilhamon, Kinjal Desai, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Frontiers in Oncology|December 15, 2022
High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first reportChia-Lin Tseng, Hanbo Chen, James Stewart, et al.
Technology in Cancer Research & Treatment|June 28, 2022
Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort AnalysisJames Stewart, Arjun Sahgal, Aimee K M Chan, et al.
The Lancet. Oncology|May 14, 2026
MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trialJay S Detsky, Adrian Wai Chan, Daniel Moore-Palhares, et al.
Data in Brief|April 14, 2021
ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastomaPejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2021
Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastomaPejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Fractionated radiotherapy for surgically resected intracranial meningiomas: A multicentre retrospective cohort studyJustin Z Wang, Farshad Nassiri, Alexander P Landry, et al.
Nature Genetics|June 22, 2026
Longitudinal changes in DNA methylation in IDH-mutant glioma fuel disease progression through altered cell state differentiationMasashi Nomura, Ramya Raviram, Joshua S Schiffman, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 5, 2024
ChatGPT and neurosurgical education: A crossroads of innovation and opportunitySaman Arfaie, Mohammad Sadegh Mashayekhi, Mohammad Mofatteh, et al.
Frontiers in Oncology|October 8, 2024
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyondAnaliz Rodriguez, Manmeet S Ahluwalia, Chetan Bettegowda, et al.
Cell Stem Cell|July 18, 2017
ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem CellsNicole I Park, Paul Guilhamon, Kinjal Desai, et al.
Pageof 24